drugset / Trial / NCT06378346
GU-01: Glycyrrhizin in Prostate Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a pilot, randomized, window-of-opportunity treatment trial in which participants with previously untreated prostate cancer (PCa) who are candidates for surgery (radical prostatectomy)
Timeline
- Start
- 2024-07-25
- Primary completion
- 2027-03
- Completion
- 2027-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Glycyrrhizin | Unknown | 75 mg | Oral |
| Subject | Glycyrrhizin | Unknown | 150 mg | Oral |